Remdesivir and All-Cause Graft Loss Among Kidney Transplant Recipients With Symptomatic COVID-19
Karan Srisurapanont, Kasama Manothummetha, Nirada Siriyakorn, Mary G. Bowring et autres
Importance: The efficacy and safety of remdesivir for COVID-19 in kidney transplant (KT) recipients across evolving pandemic eras remain unclear. Objective: To compare clinical outcomes among adult KT recipients with symptomatic COVID-19 who received early remdesivir vs those who did not receive …
us, th (code pays fourni par la source)